XML 32 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation Outstanding Options and SSARs (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
years
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Options / SSARs outstanding at January 1, 2012 8,475,000  
Incentive shares granted 343,000  
Options / SSARs exercised (1,805,000)  
Options / SSARs cancelled 0  
Options / SSARs outstanding at September 30, 2012 7,013,000  
Options / SSARs outstanding Weighted Average Exercise Price $ 14.22 $ 12.88
SSARs granted Weighted Average Exercise Price $ 20.49  
Options / SSARs exercised Weighted Average Exercise Price $ 9.13  
Options / SSARs cancelled Weighted Average Exercise Price $ 0.00  
Options / SSARs outstanding Weighted Average Contractual Term (in years) 5.7  
Options / SSARs outstanding Aggregate Intrinsic Value (in millions) $ 57.4  
Vested and expected to vest 6,663,000  
Vested and expected to vest Aggregate Intrinsic Value (in millions) 54.6  
Options / SSARs exercisable 5,719,000  
Options / SSARs exercisable Weighted Average Exercise Price $ 14.70  
Options / SSARs exercisable Aggregate Intrinsic Value (in millions) 45.2  
Director [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Starting Term When Options Become Exercisable After Grant Date 3 months  
Stock Options [Member] | Director [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Number of months for options to vest at an incremental rate of ten percent for directors 3 months  
Options and SSARs [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Weighted-average period of years costs are expected to be recognied over 1 year 10 months 24 days  
Compensation Expense 0.8  
Unrecognized compensation costs $ 6.8  
Number of Shares Available for Grant 4,300,000  
Stock Appreciation Rights (SARs) [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Vesting Period 3 years